| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |